Cargando…
First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
Autores principales: | Jia, Ziqi, Wang, Yanyu, Cao, Lei, Wang, Yadong, Song, Yang, Yang, Xiaoying, Bing, Zhongxing, Cao, Zhili, Liu, Peng, Zhang, Shuyang, Chen, Zexin, Huang, Min, Yu, Yan, Han-Zhang, Han, Song, Jinlei, Christoph, Daniel C., Passaro, Antonio, Gridelli, Cesare, Hishida, Tomoyuki, Liang, Naixin, Li, Shanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399434/ https://www.ncbi.nlm.nih.gov/pubmed/32802455 http://dx.doi.org/10.21037/jtd-20-1882 |
Ejemplares similares
-
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020) -
Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent EGFR exon 19 deletion and TP53 comutation: a case report
por: Qin, Zhiquan, et al.
Publicado: (2023) -
Diabetic ketoacidosis induced by nivolumab in invasive mucinous adenocarcinoma of the lung: a case report and review of the literature
por: Yan, Juan, et al.
Publicado: (2022) -
Chest wall trauma leading to a metallic foreign body in the right subclavian vein: a case report
por: Chen, Anping, et al.
Publicado: (2021) -
Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature
por: Lei, Xi, et al.
Publicado: (2022)